Product Details
Palivizumab Prefilled Syringe
Product Name
:
Palivizumab Prefilled Syringe
Brand Name
:
VERPALI
Available Strength
:
-
Packing
:
1 x 0.5 ml Single Dose Prefilled Syringe, with alcohol swab
Pack Insert/Leaflet
:
According To Your Needs
VERPALI is a Palivizumab formulation supplied as a sterile, ready-to-use prefilled syringe for single-dose intramuscular administration.
The injection combines:
- Palivizumab — a humanized monoclonal antibody that binds to the F protein of Respiratory Syncytial Virus (RSV), neutralizing the virus and preventing infection of respiratory tract cells
VERPALI is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants and children at high risk, including premature infants and those with chronic lung disease or congenital heart disease. As a result, it is administered under pediatric medical supervision, typically as a monthly injection during RSV season.
Key Features:
- Prefilled syringe enables convenient, accurate administration
- Sterile, single-dose format minimizes contamination risk
- Formulated specifically for intramuscular use
- Includes a sterile alcohol swab for easy, hygienic use
- Consistent, accurate dosing supports monthly prophylactic regimens
- Suitable for hospitals, pediatric clinics, and neonatal care settings